286 related articles for article (PubMed ID: 36298824)
1. Systems Bioinformatics Reveals Possible Relationship between COVID-19 and the Development of Neurological Diseases and Neuropsychiatric Disorders.
Onisiforou A; Spyrou GM
Viruses; 2022 Oct; 14(10):. PubMed ID: 36298824
[TBL] [Abstract][Full Text] [Related]
2. Exploring the Paradox of COVID-19 in Neurological Complications with Emphasis on Parkinson's and Alzheimer's Disease.
Rai SN; Tiwari N; Singh P; Singh AK; Mishra D; Imran M; Singh S; Hooshmandi E; Vamanu E; Singh SK; Singh MP
Oxid Med Cell Longev; 2022; 2022():3012778. PubMed ID: 36092161
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms highlighting the potential role of COVID-19 in the development of neurodegenerative diseases.
Rahmani B; Ghashghayi E; Zendehdel M; Baghbanzadeh A; Khodadadi M
Physiol Int; 2022 Jun; 109(2):135-162. PubMed ID: 35895572
[TBL] [Abstract][Full Text] [Related]
4. Biomedical Perspectives of Acute and Chronic Neurological and Neuropsychiatric Sequelae of COVID-19.
Stefano GB; Büttiker P; Weissenberger S; Ptacek R; Wang F; Esch T; Bilfinger TV; Raboch J; Kream RM
Curr Neuropharmacol; 2022; 20(6):1229-1240. PubMed ID: 34951387
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers for central nervous system injury in cerebrospinal fluid are elevated in COVID-19 and associated with neurological symptoms and disease severity.
Virhammar J; Nääs A; Fällmar D; Cunningham JL; Klang A; Ashton NJ; Jackmann S; Westman G; Frithiof R; Blennow K; Zetterberg H; Kumlien E; Rostami E
Eur J Neurol; 2021 Oct; 28(10):3324-3331. PubMed ID: 33369818
[TBL] [Abstract][Full Text] [Related]
6. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Encephalitis Is a Cytokine Release Syndrome: Evidences From Cerebrospinal Fluid Analyses.
Pilotto A; Masciocchi S; Volonghi I; De Giuli V; Caprioli F; Mariotto S; Ferrari S; Bozzetti S; Imarisio A; Risi B; Premi E; Benussi A; Focà E; Castelli F; Zanusso G; Monaco S; Stefanelli P; Gasparotti R; Zekeridou A; McKeon A; Ashton NJ; BlennoW K; Zetterberg H; Padovani A
Clin Infect Dis; 2021 Nov; 73(9):e3019-e3026. PubMed ID: 33395482
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 and neurodegenerative diseases.
Fu YW; Xu HS; Liu SJ
Eur Rev Med Pharmacol Sci; 2022 Jun; 26(12):4535-4544. PubMed ID: 35776055
[TBL] [Abstract][Full Text] [Related]
8. Network Meta-analysis on the Changes of Amyloid Precursor Protein Expression Following SARS-CoV-2 Infection.
Camacho RC; Alabed S; Zhou H; Chang SL
J Neuroimmune Pharmacol; 2021 Dec; 16(4):756-769. PubMed ID: 34757528
[TBL] [Abstract][Full Text] [Related]
9. Transient Changes in the Plasma of Astrocytic and Neuronal Injury Biomarkers in COVID-19 Patients without Neurological Syndromes.
Lennol MP; Ashton NJ; Moreno-Pérez O; García-Ayllón MS; Ramos-Rincon JM; Andrés M; León-Ramírez JM; Boix V; Gil J; Blennow K; Merino E; Zetterberg H; Sáez-Valero J
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769057
[TBL] [Abstract][Full Text] [Related]
10. Impact of the COVID-19 Pandemic on Chronic Neurological Disorders: Focus on Patients with Dementia.
Barbieri MA; Bagnato G; Ioppolo C; Versace AG; Irrera N
CNS Neurol Disord Drug Targets; 2022; 21(10):1017-1026. PubMed ID: 35021982
[TBL] [Abstract][Full Text] [Related]
11. Post-COVID-19 Parkinsonism and Parkinson's Disease Pathogenesis: The Exosomal Cargo Hypothesis.
Mysiris DS; Vavougios GD; Karamichali E; Papoutsopoulou S; Stavrou VT; Papayianni E; Boutlas S; Mavridis T; Foka P; Zarogiannis SG; Gourgoulianis K; Xiromerisiou G
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077138
[TBL] [Abstract][Full Text] [Related]
12. Using bioinformatic protein sequence similarity to investigate if SARS CoV-2 infection could cause an ocular autoimmune inflammatory reactions?
Karagöz IK; Munk MR; Kaya M; Rückert R; Yıldırım M; Karabaş L
Exp Eye Res; 2021 Feb; 203():108433. PubMed ID: 33400927
[TBL] [Abstract][Full Text] [Related]
13. Emerging COVID-19 Neurological Manifestations: Present Outlook and Potential Neurological Challenges in COVID-19 Pandemic.
Dewanjee S; Vallamkondu J; Kalra RS; Puvvada N; Kandimalla R; Reddy PH
Mol Neurobiol; 2021 Sep; 58(9):4694-4715. PubMed ID: 34169443
[TBL] [Abstract][Full Text] [Related]
14. Does SARS-CoV-2 affect neurodegenerative disorders? TLR2, a potential receptor for SARS-CoV-2 in the CNS.
Szabo MP; Iba M; Nath A; Masliah E; Kim C
Exp Mol Med; 2022 Apr; 54(4):447-454. PubMed ID: 35396576
[TBL] [Abstract][Full Text] [Related]
15. NOX2 Activation in COVID-19: Possible Implications for Neurodegenerative Diseases.
Sindona C; Schepici G; Contestabile V; Bramanti P; Mazzon E
Medicina (Kaunas); 2021 Jun; 57(6):. PubMed ID: 34208136
[TBL] [Abstract][Full Text] [Related]
16. Ubiquity of the SARS-CoV-2 receptor ACE2 and upregulation in limbic regions of Alzheimer's disease brain.
Zhao Y; Li W; Lukiw W
Folia Neuropathol; 2021; 59(3):232-238. PubMed ID: 34628788
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 strategically mimics proteolytic activation of human ENaC.
Anand P; Puranik A; Aravamudan M; Venkatakrishnan AJ; Soundararajan V
Elife; 2020 May; 9():. PubMed ID: 32452762
[TBL] [Abstract][Full Text] [Related]
18. Bioinformatics and systems biology approaches to identify the effects of COVID-19 on neurodegenerative diseases: A review.
Bu F; Guan R; Wang W; Liu Z; Yin S; Zhao Y; Chai J
Medicine (Baltimore); 2022 Dec; 101(49):e32100. PubMed ID: 36626425
[TBL] [Abstract][Full Text] [Related]
19. The roles of Eph receptors, neuropilin-1, P2X7, and CD147 in COVID-19-associated neurodegenerative diseases: inflammasome and JaK inhibitors as potential promising therapies.
Zalpoor H; Akbari A; Samei A; Forghaniesfidvajani R; Kamali M; Afzalnia A; Manshouri S; Heidari F; Pornour M; Khoshmirsafa M; Aazami H; Seif F
Cell Mol Biol Lett; 2022 Feb; 27(1):10. PubMed ID: 35109786
[TBL] [Abstract][Full Text] [Related]
20. Disorders of the Cholinergic System in COVID-19 Era-A Review of the Latest Research.
Kopańska M; Batoryna M; Bartman P; Szczygielski J; Banaś-Ząbczyk A
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
